Acrivon Therapeutics Inc - Preliminary Cash and Cash Equivalents and Short-Term Investments Balance of Approximately $110 Mln as of March 31, 2024
Acrivon Therapeutics Inc——截至2024年3月31日,初步現金和現金等價物以及短期投資餘額約爲1.1億美元
Acrivon Therapeutics Inc - Preliminary Cash and Cash Equivalents and Short-Term Investments Balance of Approximately $110 Mln as of March 31, 2024
Acrivon Therapeutics Inc——截至2024年3月31日,初步現金和現金等價物以及短期投資餘額約爲1.1億美元
使用瀏覽器的分享功能,分享給你的好友吧